New Bisphosphonates in the Treatment of Bone Diseases
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 15 (4) , 285-296
- https://doi.org/10.2165/00002512-199915040-00004
Abstract
Bisphosphonates are pyrophosphate analogues, in which the oxygen in P-O-P has been replaced by a carbon, resulting in a P-C-P structure. They are characterised by a strong anti-osteoclastic activity...Keywords
This publication has 78 references indexed in Scilit:
- The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding studyBone, 1996
- Administration of the bisphosphonate ibandronate (BM 21.0955) by intravenous bolus injectionJournal of Bone and Mineral Research, 1996
- Adverse Effects of BisphosphonatesDrug Safety, 1996
- Bisphosphonates and the Treatment of Bone Disease in the ElderlyDrugs & Aging, 1996
- The effects of intravenous alendronate in Paget's disease of boneJournal of Bone and Mineral Research, 1995
- Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapyJournal of Bone and Mineral Research, 1995
- ClodronateDrugs, 1994
- Drugs Used in the Treatment of Metabolic Bone DiseaseDrugs, 1993
- PamidronateDrugs, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990